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tion that is below the threshold necessary for immune-
mediated clearance. In chronically infected cell lineSummary
models of latency, there is residual viral transcription,
comprised mainly of the multiply spliced tat, rev, and nefAntiretroviral therapy is unable to eliminate HIV infec-
RNAs (Pomerantz et al., 1990). However, the constantlytion in a small, long-lived population of latently in-
activated and proliferating nature of these cells doesfected T cells, providing a source for renewed viral
not accurately represent the quiescent cellular environ-replication following cessation of therapy. Analysis of
ment of latently infected cells in vivo. The low frequencyindividual latently infected cells generated in the SCID-
of latently infected cells in the peripheral blood of HIV-hu (Thy/Liv) mouse demonstrated no functional viral
infected individuals mandates that molecular analysisRNA produced in the latent state. Following reactiva-
be performed on bulk cell populations. Thus, contamina-tion viral expression was dramatically increased, ren-
tion from productively or persistently infected cells indering the infected cells susceptible to an anti-HIV
this population can confound interpretation of the dataimmunotoxin. Treatment with the immunotoxin in con-
and, therefore, limits experimentation. Studies such asjunction with agents that activate virus expression
these have yielded conflicting results demonstrating ei-without inducing cell division (IL-7 or the non-tumor-
ther minimal or ongoing viral transcription in the latentpromoting phorbol ester prostratin) depleted the bulk
population (Chun et al., 2003; Hermankova et al., 2003).of the latent reservoir and left uninfected cells able to
Due to the importance of the latent reservoir in main-respond to subsequent costimulation. We demon-
taining infection despite therapy, a thorough under-strate that activation of latent virus is required for
standing of the molecular dynamics of HIV in the latenttargeting by antiviral agents and provide the basis for
state in primary cells is required for the design of future
future therapeutic strategies to eradicate the latent
therapeutic strategies. If the virus is truly inactive during
reservoir. latency, then therapies to render the reservoir sensitive
to an immune response or to antiviral agents would first
Introduction require viral activation. However, the increase in virus
production could potentially lead to new rounds of infec-
The use of highly active antiretroviral therapy (HAART) tion; therefore, activating factors must also be accompa-
has reduced HIV viremia in many patients to undetect- nied by agents that boost the antiviral immune response
able levels and substantially delayed the onset of AIDS; or directly target latently infected cells.
however, this treatment alone cannot completely elimi- The SCID-hu (Thy/Liv) mouse model contains coim-
nate infection (reviewed in Blankson et al., 2002; Butera, planted human fetal liver as a source of human hemato-
2000; Chun and Fauci, 1999; Ho, 1998; Pomerantz, poietic progenitor cells and human fetal thymus to pro-
2002). Following the cessation of therapy virus derived vide a microenvironment for T lymphopoiesis (McCune
from a long-lived population of latently infected T cells et al., 1988). Phenotypically and functionally normal hu-
can rekindle productive infection and progression to man T cells are generated in this system for over one
AIDS (Chun et al., 1997b, 2000; Finzi et al., 1997, 1999; year (Krowka et al., 1991). Furthermore, this model has
Ramratnam et al., 2000; Wong et al., 1997; Zhang et been used extensively to study HIV pathogenesis and
al., 2000). Unlike other suspected reservoirs that are to model therapeutic approaches to infection (reviewed
in McCune, 1992, 1996). We have previously shown that
during normal thymopoiesis cellular RNA expression de-*Correspondence: jzack@ucla.edu
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creases dramatically in mature thymocytes, and in the not accurately measure viral transcription in the latent
state due to the confounding effects of small numberscase of HIV infection, this results in a decrease in LTR-
of productively infected cells. Therefore, to properly ad-directed viral gene expression (Brooks et al., 2001).
dress the transcriptional activity of HIV in the latent state,Thus, this model provides an abundant and stable
we performed RNA analysis on individual cells employing asource of primary cells with a quiescent phenotype con-
novel single-cell, multiplex, real-time, reverse transcriptiontaining inactive virus that is reactivatible upon cellular
polymerase chain reaction. CD4 SP, muCD24 (reporter)-stimulation and thus provides a unique opportunity to
negative thymocytes were serially diluted into amplifica-study the molecular events that control HIV latency and
tion vessels such that statistically only a single celladdress these pertinent issues.
would be present in each vessel. The presence of at
most a single cell was further confirmed by microscopy.Results
Single cells were analyzed simultaneously for multiply
spliced tat/rev viral RNA and cellular 2-microglobulinCharacterization of HIV Protein and RNA Expression
(2m) RNA sequences prior to and following costim-during Latency and following Reactivation
ulation. HIV-specific primers and probes used in theseTo molecularly define the latent phenotype, we initially
studies are illustrated in Figure 2A. In vitro transcriptsinfected SCID-hu (Thy/Liv) mice with the pathogenic
were used to quantitate the number of tat/rev transcriptsreporter virus HIVNL-r-HSAS, in which the vpr gene of the
per cell, and the assay was sensitive to fewer than tenCXCR4-tropic HIVNL4-3 is replaced with the cDNA for mu-
copies of RNA (Figure 2B). The standard curves had arine CD24 (muCD24) (Jamieson and Zack, 1998). We
highly reliable correlation coefficient (r2) of 0.95have previously shown that deletion of vpr does not
(usually 0.98) in all experiments (Figure 2B). Analysisaffect viral pathogenesis or the generation of latency in
of single cells indicated that there was no detectable tat/this system (Aldrovandi and Zack, 1996; Brooks et al.,
rev transcription during latency; however, costimulation2001). To isolate a population enriched in latently in-
induced a substantial increase in both the number offected cells, Thy/Liv implants were harvested and ma-
cells making viral RNA and the number of viral RNAture CD4-positive/CD8-negative (CD4 SP), muCD24-
molecules per cell (Table 1, experiment 1). The detectionnegative thymocytes were obtained (Figure 1A). Cells
of 2m RNA in approximately 30% of the vessels in thiswere continually cultured in the presence of AZT and a
experiment further confirmed that each positive wellviral protease inhibitor to prevent in vitro virus spread.
contained only a single cell. To increase the number ofWe observed minimal viral reporter expression prior to
wells positive for cells, thymocytes were serially dilutedstimulation, which likely resulted from minor activation
to two cells per well and simultaneously analyzed forduring culture ex vivo. Indeed, we typically observe that
tat/rev and 2m transcripts (Table 1, experiment 2).1%–1.5% of cells cultured without activation progress
Based on HIV reporter expression, the frequency of la-past the G1a phase of the cell cycle (Brooks et al., 2001), tent infection in this experiment was less than 10%;consistent with the levels of viral reporter expression in
therefore, a reaction containing two cells would gener-unstimulated cultures. In contrast, costimulation with
ally have at most a single infected cell. Again, no tat/
antibodies to CD3 and CD28 to activate the T cell recep-
rev RNA was detectable in the latent population, while
tor (TcR) complex reactivated substantial amounts of
reactivation resulted in a significant increase in the fre-
latent virus and induced viral reporter expression (Figure
quency of cells expressing tat/rev RNA (p  0.002 when
1A). Expression of the viral structural protein gag was experiments 1 and 2 are combined) and in the magnitude
also not detected in the latent population while gag of this expression. To more sensitively examine HIV tran-
expression dramatically increased following viral reacti- scription, we performed additional studies of individual
vation (Figure 1B), further demonstrating the dormancy cells by amplifying cellular and viral RNA in separate
of HIV in the latent state. Similar results were observed (nonmultiplexed) reactions (Figure 2B). Interestingly, tat/
with wild-type CCR5-tropic HIVJR-CSF and wild-type rev RNA expression was detected in one cell on day 0,
CXCR4-tropic HIVNL4-3 (Brooks et al., 2001). It is unclear albeit at an extremely low level (Table 1, experiment 3).
whether the low level background gag staining observed This may be due to a small level of transcriptionally
in the small proportion of isolated cells (Figure 1B, day active cells in the mature thymocyte population. None-
0) is an antibody sensitivity issue, or whether there is theless, costimulation similarly increased the frequency
residual p24 remaining from a time when productive of cells expressing viral RNA (p  0.0016) and resulted
infection ensued, prior to the onset of latency. However, in a greater than 100-fold increase in tat/rev transcription
the level of staining we see on day 0 remained the same from previously nontranscribing cells (p  0.007), indi-
at day 2 of culture without stimulation (data not shown), cating the transcriptional dormancy of HIV in the la-
suggesting that it may be due to a level of activated tent state.
cells remaining at the time of purification or to de novo In the absence of tat, elongation of HIV RNA is abortive
activation of latent virus occurring during isolation. In (Feinberg et al., 1991; Marciniak and Sharp, 1991); there-
control studies performed in the absence of protease fore, we determined whether there might be basal LTR
inhibitor and AZT, we recovered virus following costim- activity during latency. As opposed to multiply spliced
ulation that was able to transfer infection to new target tat/rev RNA, which was absent in the same experiment,
cells (data not shown). Thus, the latent virus is replica- we detected low levels (average 20 copies per infected
tion competent and not derived from a defective form. cell) of LTR/gag transcripts prior to costimulation (Table
Past studies to assess viral RNA transcription during 2, experiment 3). This low-level expression was easily
latency have utilized bulk populations containing la- distinguishable from levels of LTR/gag RNA seen follow-
ing costimulation (average 684 copies per infected cell;tently infected cells. However, this type of analysis may
Elimination of Latent HIV-1
415
Figure 1. Reactivation of Latent Virus In-
duces HIV Protein Expression
(A) HIVNL-r-HSAS-infected CD4 SP, muCD24-
negative thymocytes (Day 0) were cultured
without stimulation or costimulated with anti-
bodies to CD3 and CD28 for 3 days (Day 3)
and assessed for cellular granularity (SSC)
and HIV (muCD24) expression by flow cytom-
etry. The percentage of muCD24-positive
cells is indicated in each panel. The concen-
tration of viral p24 gag in the supernatant is
shown next to each panel.
(B) HIVNL-r-HSAS-infected CD4 SP, muCD24-
negative thymocytes (Day 0) were assessed
for cellular granularity and the expression of
intracellular HIV gag during latency (Day 0)
and following costimulation (Day 2). The top
and bottom panels illustrate two different ex-
periments with the percentage of HIV gag-
expressing cells given in each plot.
Table 2). Hence, costimulation did not significantly in- been successful in eradicating the latent reservoir (Chun
crease the number of cells expressing LTR/gag tran- et al., 1999a, 1999b; Prins et al., 1999; Stellbrink et al.,
scripts (p  0.67); however, costimulation did induce a 2002; van Praag et al., 2001). One potential approach is
greater than 30-fold increase in the amount of LTR/ the use of immunotoxins (ITs) (reviewed in Engert et
gag transcripts in each infected cell (p  0.0003). In a al., 1998; Pastan and Kreitman, 1998); in particular, ITs
separate experiment, similar levels of LTR/gag tran- directed toward the HIV envelope glycoprotein have
scripts were observed during latency; however, there been suggested as an approach to attack the infected
was no detectible amplification of RNA sequences from cell reservoirs persisting after antiretroviral therapy (Ber-
the 3 end of the viral genome (data not shown). These ger et al., 1998). A molecular conjugate containing the
3 primers should detect all viral RNA species including effector domains of the Pseudomonas exotoxin A linked
full-length genomic RNA, indicating that the residual to a single chain antibody with specificity for the highly
viral RNA we observed with the LTR/gag primers con- conserved CD4 binding site of gp120 (3B3:N31H/
sists of abortive transcripts. Q100eY[dsFv]-PE) is able to kill cells productively in-
fected with diverse CCR5- and CXCR4-tropic strains of
HIV while sparing uninfected cells (Bera et al., 1998;Costimulation of Latently Infected Cells Renders
Goldstein et al., 2000; McHugh et al., 2002). To ascertainThem Susceptible to an Anti-HIV Immunotoxin
whether latently infected cells were sensitive to lysisGiven the functionally dormant transcriptional state of
with the anti-HIV IT, CD4 SP, muCD24-negative cellslatent HIV, therapies to render the latent reservoir sensi-
from HIVNL-r-HSAS infected mice were incubated for 4 hrtive to an immune response or to antiviral therapies
with either the active IT or an inactive IT carrying a pointwould likely require viral reactivation. However, imple-
mentation of these strategies in patients have not yet mutation that renders the toxin moiety enzymatically
Immunity
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Figure 2. Primer/Probe Locations and Standard Curves for Real-Time PCR Quantitation
(A) Boxes represent individual coding sequences of the HIV genome. RNA transcripts that encode full-length gag/pol and multiply spliced
tat/rev are also depicted. HIV-specific primers (arrowed lines) and probes (filled circles) are shown. Dotted lines indicate introns. The tat/rev
sense primer overlaps the first splice junction and does not amplify viral DNA.
(B) In vitro-transcribed tat/rev RNA was serially diluted to generate standard curves to quantitate HIV expression. The standards are 10-fold
dilutions of tat/rev RNA ranging from 100,000 copies to 10 copies and are shown next to each curve. A sample negative for HIV sequences
is shown and marked as 0. The top panel (multiplexed) is a representative standard curve in which both cellular and viral RNAs were coamplified
in the same reaction. The bottom panel is representative of a nonmultiplexed reaction. The x axis indicates the cycle number of the PCR
amplification. The y axis indicates the magnitude of the signal generated by the given reaction at the corresponding cycle. The inset graph
shows the correlation coefficient (r2) between the in vitro-transcribed standards (RNA Quantity, x axis) versus the threshold cycle number at
which the signal is positive (Ct, y axis).
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Table 1. Quantitation of tat/rev Transcription during Latency and following Reactivation
Totala Cell RNAb T/R Positivec % Positived % muCD24e % HIV DNAf
Expt 1 US 164 36 0 0 1 15
CS 82 30 2 7 4
Expt 2 US 72 59 0 0 1 ND
CS 72 72 6 8 6
Average copy number: unstimulated, 0 copies; costimulated, 272 copies
Expt 3 US 72 45 1 2 1 29
CS 78 78 16 21 11
Average copy number: unstimulated, 5 copies; costimulated, 536 copies
In experiments 1 and 2, individual CD4 SP, muCD24-negative thymocytes were simultaneously analyzed by multiplex RT-PCR immediately
following isolation on day 0 (US, unstimulated) and 2 days following costimulation (CS, costimulated) for viral tat/rev and cellular 2m transcripts.
These two experiments were performed under identical conditions, so the data were combined to generate average copy number values. In
experiment 3, nonmultiplexed RT-PCR amplification was performed for viral tat/rev and cellular TcR RNA. ND, not done.
a The number of wells on the PCR plate that received serially diluted aliquots.
b The number of wells positive for cellular 2m or TcR RNA.
cThe number of wells positive for both cellular and viral tat/rev RNA.
d The percentage of wells positive for both tat/rev and 2m RNA.
e The percentage of cells that expressed HIV reporter following 3 day costimulation, as assessed by flow cytometry.
f The percentage of CD4 SP, muCD24-negative cells containing completely reverse-transcribed viral DNA.
inactive (McHugh et al., 2002). The ITs were then re- the presence or absence of vpr does not influence the
generation or reactivation of latent virus, and that themoved and the cells were costimulated for 3 days. Prein-
cubation of the cells with the IT did not inhibit subse- immunotoxin is effective against both CCR5- and
CXCR4-tropic strains of HIV. The inability of the inactivequent reactivation of virus expression (Figure 3A),
although treatment of productively infected cells for the control IT to reduce virus expression indicates that the
depletion observed with the active IT is a direct resultsame amount of time depleted HIV expression (data
not shown). In contrast, the presence of the IT during of the toxin moiety and not due to inhibition of viral
spread or to the immunoglobulin domain.costimulation almost completely eliminated produc-
tively infected cells while the inactive IT had no effect
(Figure 3A). Moreover, the low levels of viral p24 in the Prostratin and IL-7 Both Confer Susceptibility
to the IT without Affecting the Subsequentsupernatant of cells treated with the active IT (Figure
3A) indicates that the reactivated virus-producing cells Response to Stimulation
A strategy to purge the latent reservoir must have mini-were killed prior to the production of free virus. Thus,
the IT does not affect latently infected cells; however, mal effects on global T cell activation, so as not to
perturb immune function. We have demonstrated thatonce viral gene expression is reactivated the infected
cells quickly become susceptible to recognition and both IL-7 (Scripture-Adams et al., 2002) and the non-
tumor-promoting phorbol ester prostratin (Korin et al.,elimination by the IT. Similar results were observed with
the IT in splenocytes from HIVNL-r-HSAS-infected SCID-hu 2002) potently induce latent virus from quiescent, pri-
mary T cells without altering the maturation state ormice following costimulation (data not shown). Thus,
latently infected peripheral cells behave similarly to thy- initiating global proliferation of uninfected cells. Impor-
tantly, prostratin induces expression of latent virus frommocytes. Importantly, costimulation plus immunotoxin
treatment of mature CD4 SP thymocytes from SCID-hu peripheral blood mononuclear cells of HIV-infected pa-
tients (Kulkosky et al., 2001). Addition of either IL-7 (Fig-mice infected with the wild-type, CCR5-tropic primary
isolate HIVJR-CSF resulted in a greater than 80% decrease ure 4) or prostratin (Figure 4) during latency induced
substantial HIV gene expression. Reactivation of HIVin viral p24 expression, while the inactive IT had no effect
(Figure 3B). Preincubation of these cells with the IT prior protein expression by IL-7 or prostratin rendered in-
fected cells susceptible to the IT (Figure 4), while theto activation did not inhibit subsequent reactivation of
latent virus (data not shown). These results indicate that inactive control IT did not inhibit HIV reactivation or
Table 2. Quantitation of LTR/gag Transcription
Totala Cell RNAb L/g Positivec % Positived % muCD24e % HIV DNAf
Expt 3 US 70 46 6 13 1 29
CS 69 69 11 16 11
Expt 4 US 70 42 1 2 1 20
CS 70 70 3 3 4
Average copy number: unstimulated, 20 copies; costimulated, 684 copies
Nonmultiplexed RT-PCR was performed to amplify viral LTR/gag and cellular TcR RNA. The legend is as described in Table 1, except c refers
to the number of wells positive for both cellular TcR and viral LTR/gag transcripts. The average number of LTR/gag transcripts per infected
cell is provided.
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Figure 4. IL-7 and Prostratin Reactivate Latent Virus and Allow Kill-
ing of Infected Cells by the IT
HIVNL-r-HSAS-infected CD4 SP, muCD24-negative thymocytes were in-
cubated in the presence of IL-7 alone, or with IL-7 and either the
IT or control IT (top panels), or incubated in the presence of
prostratin alone, prostratin plus the IT, or prostratin with the control
IT (bottom panels) for 3 days. Cells were then analyzed for HIV
(muCD24) expression and viral p24 production. The prostratin data
are from the same experiment as shown in Figure 3. The IL-7 data
are from a separate experiment in which 3% of cells cultured without
stimulation for 3 days expressed muCD24 and unstimulated cultures
contained 4 ng/ml p24, while 11% of costimulated cells expressed
muCD24 and 57 ng/ml p24 in the culture (data not shown). The
percentage of muCD24-positive cells is indicated in each panel, and
p24 production is shown below each panel.
To determine the ability of cells to respond to activat-
ing stimuli following treatment with IL-7 or prostratin,
thymocytes were treated with either agent or left un-
treated for 3 days, rinsed to remove the agents, and
subsequently subjected to costimulation. Pretreatment
with IL-7 did not perturb the ability of uninfected cells
to become subsequently activated and undergo blast
transformation in response to costimulation (Figure 5A).
Furthermore, following costimulation 90% of the cells
expressed the  chain of the interleukin 2 receptorFigure 3. Viral Reactivation Is Necessary for Killing by the IT
(CD25), a marker of cellular activation (Figure 5B). Impor-(A) CD4 SP, muCD24-negative thymocytes from HIVNL-r-HSAS-infected
tantly, total cellular viability remained high (75%) withThy/Liv implants were either cultured without stimulation or were
costimulated for 3 days (top panels), incubated on day 0 with the this treatment. Viability was actually slightly higher in
anti-HIV IT or inactive IT for 4 hr prior to costimulation, then washed the presence of IL-7, suggesting that there may be some
to remove the ITs and costimulated for 3 days (middle panels), or effect of the cytokine on cell responses. In fact, IL-7 is
costimulated in the presence of the IT or inactive IT for 3 days known to potentiate T cell receptor-mediated signaling(bottom panels). On day 3 cells were assessed for HIV reactivation.
(Fry and Mackall, 2002). Costimulation following prostratinThe percentage of HIV (muCD24)-positive cells is provided in each
treatment similarly caused blast transformation (Figureplot. p24 gag production was determined by ELISA and is provided
to the right of each plot. 5A) and CD25 expression (Figure 5B); however, cellular
(B) The IT kills wild-type, CCR5-tropic HIV isolates following viral viability was lower (50%) than that observed without
reactivation. CD4 SP thymocytes from HIVJR-CSF-infected SCID-hu initial stimulation or with IL-7 treatment followed by co-
(Thy/Liv) mice were cultured without stimulation, were costimulated, stimulation (Figure 5A).or were costimulated in the presence of the IT or inactive IT for 3
To quantitate the effect of these treatments plus thedays. p24 gag production in each culture was quantitated by ELISA
IT on the latent reservoir, latently infected thymocyteson day 3 and is shown in the graph.
were treated with either IL-7 or prostratin and the IT or
inactive IT for 3 days and costimulated. Preincubation
with IL-7 plus the IT resulted in approximately a 70%virus production. Furthermore, none of these treatments
substantially affected total cellular viability, which was decrease in de novo virus production and decreased
the number of cells producing virus following costim-between 70% and 80% (data not shown).
Elimination of Latent HIV-1
419
Figure 5. IL-7 or Prostratin plus IT Treatment
Depletes the Latent Reservoir without Im-
pairing Subsequent Cellular Responses
(A) CD4 SP thymocytes from SCID-hu (Thy/
Liv) implants were preincubated without stim-
ulation, with IL-7, or with prostratin for 3 days
and washed. The cells were then washed and
costimulated without IL-7 or prostratin for 2
days. Forward (FSC)/side scatter (SSC) pro-
files for each condition are shown. Viable
cells on day 5 are indicated within the gate,
and the percentage of these cells is provided
in each plot.
(B) CD4 SP thymocytes cultured as in Figure
5A were analyzed on day 5 by flow cytometry
to assess the percentage of activated (CD25-
positive) cells following costimulation. The
percentage of CD25-expressing cells is indi-
cated in each histogram. Fewer cells were
acquired in the isotype control due to limited
cell numbers.
(C) HIVNL-r-HSAS-infected CD4 SP, muCD24-
negative thymocytes from the same experi-
ments as shown in Figure 4 were preincu-
bated with IL-7 plus the IT or inactive IT, or
prostratin plus the IT or inactive IT for 3 days.
The cells were then washed and costimulated
without IL-7, prostratin, or the ITs for 2 days.
The percentage of HIV (muCD24)-positive
cells was then assessed by flow cytometry
(left panels). Viral p24 gag production in the
supernatant was quantitated by ELISA
(right panels).
ulation by over 50%, as compared to costimulated cells IL-7 or prostratin pretreatment did not interfere with the
ability of the cells to respond to subsequent costim-previously cultured with the inactive IT (Figure 5C). Co-
stimulation of cells pretreated with prostratin plus the ulation, as 100% of the T cells expressed CD25 following
costimulation and underwent blast transformation (dataIT caused an 80% decrease in viral p24 production and
a 70% decrease in the number of cells containing activa- not shown). Thus, both IL-7 and prostratin were able to
induce virus expression from latency and render thetion-inducible virus versus cells similarly cultured with
the inactive IT (Figure 5C), indicating that these treat- cells susceptible to killing by the IT, with minimal effects
on the subsequent functionality of uninfected cells.ments effectively deplete the latent reservoir.
The majority of latently infected cells in humans are
in the periphery or in lymph nodes (Chun et al., 1997a); Discussion
therefore, we tested the effects of IL-7 or prostratin on
normal, uninfected peripheral blood lymphocytes (PBL), Our studies demonstrate in primary cells the functional
dormancy of HIV in the latent state and consequently,which tend to have a greater survival in culture than
thymocytes. Costimulation of PBL previously cultured the necessity for viral reactivation for recognition by
antiviral agents. The highly sensitive (less than ten cop-with IL-7 or prostratin for 3 days did not greatly decrease
cellular viability compared to cells costimulated without ies of viral RNA), single-cell analysis used herein over-
comes the problems associated with RNA analysis fromprior treatment with these agents (100% viability for PBL
pretreated with IL-7 and 85% viability for PBL pretreated bulk populations of cells and, contrary to cell line models
of latency, demonstrates that there is minimal, nonpro-with prostratin relative to untreated controls). Similarly,
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ductive transcription from the viral LTR during HIV la- quency of latently infected cells (Table 2, experiment 4),
the percentage of cells containing LTR/gag transcriptstency generated in this system. Although we did not
analyze the levels of nef transcripts during latency, it is during latency and following costimulation was similar,
thus illustrating the sensitivity of the assay at the cellularwell established that productive HIV replication does
not occur in the absence of tat production (Feinberg et level and arguing against potential sampling error as an
explanation for our results.al., 1991; Marciniak and Sharp, 1991). Thus, it is likely
the absence of tat during latency that prevents the ex- The identification of low-level, nonfunctional HIV tran-
scriptional activity suggests that latency is not neces-tension of the few RNA transcripts initiated by basal
LTR activity. Of the many cells analyzed we were only sarily maintained by active inhibition of the LTR, but
instead that there is a lack of specific cellular proteinsable to identify tat/rev RNA in one cell in the latently
infected population, albeit at an extremely low level (Ta- in quiescent T cells that are necessary for productive
viral expression. Exactly which factors these are is cur-ble 1). This cell probably represents those cells responsi-
ble for the low-level ex vivo activation that we observe rently unclear, but in their absence the virus is dormant.
Since IL-7 and prostratin alone are sufficient to reacti-in unstimulated cultures and the small percentage of
cells that express HIV-reporter following 3 days in cul- vate latent virus while only causing minimal cell cycle
progression, these cellular transcription factors mustture without exogenous stimulation. Nonetheless, the
majority of cells were not making tat/rev transcripts dur- be induced early following stimulation and prior to a
substantial increase in cellular RNA production (Brooksing latency, while they could be induced to do so follow-
ing costimulation (Table 1). There are, however, low lev- et al., 2001; Korin et al., 2002; Scripture-Adams et al.,
2002). However, our studies do not rule out other possi-els of LTR/gag transcripts in these cells during latency,
even in the absence of tat/rev transcripts (compare Ta- ble mechanisms to generate latent infection in humans,
such as epigenetic modification of the viral LTR or localbles 1 and 2, experiment 3). The percentage of cells
expressing LTR/gag transcripts does not change follow- chromatin structure (Jordan et al., 2001).
It is likely that the lack of viral antigen expressioning viral reactivation, but rather there is a 40-fold in-
crease in the magnitude of expression. Therefore, it ap- ultimately contributes to the persistence of the latent
reservoir and allows for immune evasion. The inabilitypears that the viral LTR is capable of basal activity during
latency, but the cell is missing factors, such as tat, that of the HIV-specific IT to target latently infected cells,
while efficiently killing virus-expressing cells, demon-are required for processivity and completion of full-
length transcription. Adams et al. previously identified strates that elimination of the latent reservoir may first
require viral reactivation. Since the factors that supportabortive, promoter-proximal HIV transcripts as the pre-
dominant viral RNA species in peripheral blood mononu- HIV reactivation are produced early in the cell cycle
(Brooks et al., 2001; Korin et al., 2002; Scripture-Adamsclear cells from asymptomatic HIV-positive patients
(Adams et al., 1994). In their study, without cellular stimu- et al., 2002), only minimal, but appropriate, stimulation
is necessary. Strategies aimed at activating latently in-lation these transcripts did not proceed to the U5 region
of the 5 LTR. In our studies there is at least some fected cells to express viral proteins in patients on
HAART have not yet been successful in eradicating in-transcription through the 5 LTR into the early gag region
of the genome; however, similar to the studies by Adams fection (Chun et al., 1999a, 1999b; Kulkosky et al., 2002;
Prins et al., 1999; Stellbrink et al., 2002; van Praag etet al., transcription does not proceed to the 3 end of the
genome. The differences in the lengths of the aborted al., 2001). Thus, a small animal system to rapidly preclini-
cally test and quantitatively compare potential therapeu-transcripts seen in these studies may reflect the different
sensitivities of the assays used (real-time RT-PCR ver- tic agents to eliminate the latent reservoir would be
advantageous. We have demonstrated the ability of IL-7sus standard RT-PCR). In addition, we did not utilize
primers that would specifically assess transcripts of or prostratin plus the IT to simultaneously reactivate
and eliminate greater than 50% to 70% of the latentshorter length. Nonetheless, the results are primarily the
same, as we also show that HIV in the latent state does reservoir, while maintaining cell phenotype (Korin et al.,
2002; Scripture-Adams et al., 2002) and, importantly,not produce complete RNA transcripts.
Due to the large number of individual cells analyzed maintaining the ability of uninfected cells to respond to
subsequent costimulation. Recently, Fry et al. showedat each time point, the frequency of latently infected
cells (determined by reporter staining 3 days after co- that administration of IL-7 to SIV-infected macaques
caused acute, reversible lymphoproliferation of both na-stimulation; Table 1), and the general reproducibility of
the PCR results within and over several separate experi- ive and memory T cells (Fry et al., 2003). Although these
studies did not address the effects of IL-7 on the latentments, it is unlikely that sampling error can account for
the lack of cells expressing virus prior to activation. reservoir, together with our earlier studies showing that
the effects of IL-7 are similar on naive and memoryThe absolute number of infected cells does not change
between conditions because the sample is split and T cells (Scripture-Adams et al., 2002), these data sug-
gest that IL-7 should also reactivate latent HIV in mem-then either subjected to stimulation or analyzed without
stimulation. Thus, the increase in the number of viral ory T cells, the major reservoir in humans (Pierson et
al., 2000). The efficient killing by the IT considerablyRNA-producing cells evident following costimulation is
due to direct activation of viral gene expression. Further- minimizes virus production and, accordingly, the poten-
tial for viral spread, a possible problem associated withmore, the presence of LTR/gag transcripts (Table 2) in
the same percentage of cells during latency and follow- agents that reactivate virus expression. Moreover, in
vivo the IT could potentially target other reservoirs ofing costimulation (albeit at very different copy numbers)
indicates that we are accurately quantifying cells con- infection, such as macrophages and dendritic cells, to
further eliminate infection. Because the high-affinity im-taining viral RNA. Even in experiments with low fre-
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negative individuals and peripheral blood mononuclear cells weremunoglobulin variable region present in the IT retains the
isolated over a Ficoll-Paque gradient with subsequent depletion ofbroad crossreactivity of the 3B3 antibody, IT-resistant
adherent cells. All cells were cultured in RPMI 1640 supplementedenvelope mutants are unlikely to arise (McHugh et al.,
with 2% human AB serum, 100 U/ml of penicillin, 100 g/ml strepto-
2002). The relatively nontoxic nature of prostratin and mycin, 2 mM L-glutamine, 100 nM Indinavir, and 10 M AZT.
particularly IL-7 makes them appealing therapeutic can- Thymocytes and PBL were costimulated with plate-bound anti-
CD3 and soluble anti-CD28 as described (Brooks et al., 2001). Tendidates for further study. Thus, in individuals where virus
micromolar prostratin or 10 ng/ml IL-7 was added to the cultureslevels are being suppressed by therapy it might be feasi-
where indicated. The functional IT (3B3:N31H/Q100eY[dsFv]-PE)ble to coadminister several pulses of an agent such as
was expressed and purified from bacteria as described (Bera et al.,IL-7 or prostratin in combination with the IT to systemati-
1998; McHugh et al., 2002). The inactive control IT carries an Asp553
cally reactivate and purge the latent reservoir. point mutation that renders the Pseudomonas exotoxin A moiety
The SCID-hu mouse may not accurately represent the enzymatically inactive (McHugh et al., 2002). Thymocytes were incu-
bated with 1 g/ml of the IT or inactive IT as indicated.primary cell type (CD4 memory) that is latently infected
in humans, and in some SIV systems evidence of a
thymic reservoir is lacking (Shen et al., 2003). However, Flow Cytometry
To assess intracellular gag expression, thymocytes were permeabil-in these studies we have used thymopoiesis as a model
ized with 0.2% Tween and stained with the anti-HIV gag monoclonalto generate latently infected cells. Due to the ex vivo
antibody KC57 (Coulter). Samples were analyzed on a FACSCaliburnature of these experiments the exact extent to which
flow cytometer using the Cell Quest Program (Becton Dickinson,
they apply to natural infection is not known; however, Mountain View, CA). Forward versus side scatter profiles were used
the viral RNA expression we observe in latently infected to define the live population and assess cellular activation. In all
experiments cells were stained and gated on the human CD45-cells agrees with the recent data by Hermankova et al.
positive population to exclude murine cells. HIV reporter and gagusing peripheral blood lymphocytes from HIV-infected
staining quadrants were set such that uninfected cells treated inpatients (Hermankova et al., 2003). Furthermore, the
parallel had less than 1% muCD24 or KC57 expression. Other quad-long-term persistence of latent virus in HIV-infected indi-
rants were set based on isotype controls from mock-infected cells.
viduals (Finzi et al., 1999; Ramratnam et al., 2000) sug- PBL were stained with antibodies to CD3 and CD25 (Coulter). For
gests a similar mechanism of immune evasion as dis- T cell analysis, PBL were gated on CD3 expression.
cussed here, wherein latent viral transcription is minimal
and latently infected cells are invisible to the immune RNA Analysis
CD4 SP, muCD24-negative cells were serially diluted such that anresponse. Importantly, our results provide proof of prin-
aliquot containing at most a single cell (confirmed by light micros-ciple that latently infected cells can be depleted while
copy) was transferred into a 96-well Taqman plate for RT-PCR analy-leaving uninfected cells functional. While further testing
sis (Applied Biosystems, Foster, CA). Single-cell, real-time, multi-in more complex in vivo systems such as SIV-infected
plex, reverse transcription and PCR amplification was performed
macaques is necessary, our study provides hope that simultaneously for viral tat/rev and cellular 2m RNA with the Qiagen
strategies will be identified that may ultimately lead to One Step RT-PCR kit (Qiagen, Chatsworth, CA) using the manufac-
turer’s protocol. In indicated experiments, cells were serially dilutedthe depletion of viral reservoirs.
such that each well received two cells. Only wells positive for cellular
2m transcripts were considered to contain cells. To determine theExperimental Procedures
frequency of cells in nonmultiplexed reactions (where cellular and
viral RNA were amplified in different reactions), cellular TcR se-Infection of SCID-hu Mice
SCID-hu mice were prepared by implantation of human fetal liver quences were amplified in different wells on the same PCR plate.
To quantitate the number of tat/rev, LTR/gag, or full-length viraland thymus (Advanced Bioscience Resource, Alameda, CA) as de-
scribed (Brooks et al., 2001). Thy/Liv implants were mock infected transcripts, in vitro-transcribed standards were generated (Pro-
mega, Madison, WI). Serial dilutions of each in vitro transcript werewith medium, with the CXCR4-tropic strain HIVNL-r-HSAS or with the
wild-type, CCR5-tropic, primary isolate HIVJR-CSF by direct injection added to wells that contained two uninfected cells, to mimic amplifi-
cation of RNA from intact cells, and amplified in parallel with the(Brooks et al., 2001). HIVJR-CSF was originally isolated from the cere-
brospinal fluid of an HIV-infected individual. To prevent mutations test samples. The in vitro transcripts were detectible to below ten
RNA copies. 3 viral RNA transcripts were amplified in nonmulti-that arise during reverse transcription, viral stocks of HIVJR-CSF were
prepared by electroporation of cloned proviral DNA into HeLa-tat plexed reactions. HIV LTR/gag and 2m primers have been de-
scribed (Brooks et al., 2001). The LTR/gag primers flank the firstcells, which produce virus but are resistant to de novo infection.
HIVNL-r-HSAS was prepared as previously described (Brooks et al., splice donor (SD1) site in HIV. The forward tat/rev primer was de-
signed to cross intron 1 and does not amplify viral DNA. The tat/2001). p24 gag protein production during culture was assessed by
enzyme-linked immunosorbent assay (ELISA, Coulter, Hialeah, FL). rev primer and probe sequences are: T/R sense, 5-GGGCGGCGAC
TGAATTGGGT-3; T/R antisense, 5-CCGCTTCTTCCTGCCATAG
GAGATG-3; T/R probe, 5-6FAM-ACAAGCAGTTTTAGGCTGACTTCell Isolation, Culture, and Treatment
Thy/Liv implants were harvested 5 weeks postinfection, and single- CCTGGATGC-Tamra-3. The primer/probe pair to identify 3 HIV
transcripts amplify sequences in the nef coding region and flankcell suspensions of thymocytes were immediately pooled in the
presence of 100 ng/ml Indinavir (Merck, West Point, PA) and 10 the Xho1 site and are: 3 sense, 5-TGAGACGAGCTGAGCCAGCAG-
3; 3 antisense, 5-CTGAGGTGTGACTGGAAAACCCA-3; FL probe,M AZT (Sigma, St. Louis, MO). Thymocytes from mock-infected
implants were isolated and cultured in parallel for each condition. 5-6FAM-TCGAGATACTGCTCCCACCCCATCT-Tamra-3. The TcR
primer and probe pair amplify the constant  region and their se-To enrich for CD4 SP latently infected thymocytes, total thymocytes
were stained with antibodies to human CD8 (Miltenyi, Auburn, CA) quences are: TcR sense, 5-GGAAGGAGGTGCACAGTGGG-3; TcR
antisense, 5-CAGACAGGACCCCTTGCTGG-3; TcR probe, 5-VIC-and negatively selected by using the autoMacs Magnetic Cell Sorter
(Miltenyi). These cells were then stained with a rat antibody to murine TCTCGGAGAATGACGAGTGGACCC-Tamra-3. The LTR/gag probe
sequence is 5-6FAM-TTTGGCGTACTCACCAGTCGCCGC-Tamra-CD24 (muCD24; Pharmingen, San Diego, CA) and depleted of pro-
ductively infected cells by panning in flasks coated with rabbit anti- 3 and crosses the SD1 site. The 2m probe sequence is 5-VIC-
TCCAAATGCGGCATCTTCAAACCTCCA-Tamra-3. The amplifica-rat antibody (Sigma). Purity was assessed by flow cytometry using
different antibody clones to avoid epitope masking. In all experi- tion products from each primer pair were sequenced to ensure
specificity. All RT-PCR amplifications were performed on thements less than 1% of the isolated cells expressed CD8 or viral
reporter (muCD24). Peripheral blood was obtained from HIV-sero- ABI7700 (Applied Biosystems) and subjected to a reverse transcrip-
Immunity
422
tion stage at 50C for 30 min and 55C for 10 min. The reactions Chun, T.W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J.A., Taylor,
H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T.C., et al.were then heated to 95C for 15 min. The PCR was then carried out
for 50 cycles at 95C for 15 s, 55C for 30 s, and 60C for 90 s. The (1997a). Quantification of latent tissue reservoirs and total body viral
load in HIV-1 infection. Nature 387, 183–188.LTR/gag and full-length primers potentially amplify DNA; therefore,
to rule out DNA background the diluted cells were added to multiple Chun, T.W., Stuyver, L., Mizell, S.B., Ehler, L.A., Mican, J.A., Baseler,
wells on the same plate and the reverse transcription stage of the M., Lloyd, A.L., Nowak, M.A., and Fauci, A.S. (1997b). Presence of
reaction was performed in the absence of enzyme. PCR mix (con- an inducible HIV-1 latent reservoir during highly active antiretroviral
taining the DNA polymerase) was then subsequently added. No therapy. Proc. Natl. Acad. Sci. USA 94, 13193–13197.
amplification was detected in the absence of reverse transcription.
Chun, T.W., Davey, R.T., Jr., Engel, D., Lane, H.C., and Fauci, A.S.
(1999a). Re-emergence of HIV after stopping therapy. Nature 401,DNA Analysis
874–875.Quantitative, real-time DNA PCR was performed as previously de-
Chun, T.W., Engel, D., Mizell, S.B., Hallahan, C.W., Fischette, M.,scribed (Gorry et al., 2001) using a primer/probe pair that amplifies
Park, S., Davey, R.T., Jr., Dybul, M., Kovacs, J.A., Metcalf, J.A., etcellular -globin sequences and one that amplifies full-length HIV
al. (1999b). Effect of interleukin-2 on the pool of latently infected,reverse transcripts (LTR/gag junction), formed near the completion
resting CD4	 T cells in HIV-1-infected patients receiving highlyof the reverse transcription process. All amplifications were per-
active anti-retroviral therapy. Nat. Med. 5, 651–655.formed on the ABI7700.
Chun, T.W., Davey, R.T., Jr., Ostrowski, M., Shawn Justement, J.,
Statistical Analysis Engel, D., Mullins, J.I., and Fauci, A.S. (2000). Relationship between
Independent single-cell, RT-PCR experiments were pooled as indi- pre-existing viral reservoirs and the re-emergence of plasma viremia
cated to ensure sufficient power to conduct analysis. Fisher’s exact after discontinuation of highly active anti-retroviral therapy. Nat.
test was used to determine whether the number of cells expressing Med. 6, 757–761.
viral RNA following costimulation was significantly different than Chun, T.W., Justement, J.S., Lempicki, R.A., Yang, J., Dennis, G.,
in unstimulated cells. Comparisons of viral RNA copy numbers in Jr., Hallahan, C.W., Sanford, C., Pandya, P., Liu, S., McLaughlin, M.,
unstimulated and costimulated single cells were conducted using et al. (2003). Gene expression and viral prodution in latently infected,
a two-sided Wilcoxin rank sum test. resting CD4	 T cells in viremic versus aviremic HIV-infected individ-
uals. Proc. Natl. Acad. Sci. USA 100, 1908–1913.
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